Hemophilia is a rare, genetic disorder characterized by the inability of the blood to clot normally. This blood disorder is often inherited, passed down from generation to generation, and affects the male population predominantly. Hemophilia results from a deficiency in one of the vital clotting factors in the blood, which are proteins necessary for blood clotting.

There are two primary types of hemophilia: Hemophilia A (also known as classic hemophilia), which accounts for approximately 80 percent of all cases, and occurs when the body lacks enough clotting Factor VIII. Hemophilia B (Christmas disease) is the second most common type, triggered by the deficiency of clotting Factor IX. Both of these deficiencies prevent the body from forming blood clots effectively, causing prolonged bleeding after an injury, easy bruising, and an increased risk of bleeding inside joints or the brain.

The manifestations of hemophilia can be severe, especially in the event of an internal bleed. Symptoms typically manifest in childhood and may include unexplained and often excessive bleeding from cuts or injuries, or after surgery or dental work; many large or deep bruises; unusual bleeding after vaccinations, pain, swelling or tightness in the joints; and unexplained nosebleeds or blood in the urine or stool. Hemophilia suffering infants may also experience unexplained irritability.

Hemophilia diagnosis is often grounded on personal and family medical histories, a physical examination, and specific blood tests known as clotting factor tests. Once diagnosed, although there's no cure yet, hemophilia can be effectively managed with replacement therapy. This involves infusions of concentrated clotting factors, which can either be given after a bleeding episode (on-demand therapy) or regularly to prevent bleeding episodes (prophylactic therapy).

Undeniably, life with hemophilia can be challenging. Having the disorder doesn’t merely implicate physical pain; it also warrants a heavy emotional burden. Nonetheless, with the right coping strategies and treatment, individuals with hemophilia can lead healthy lives. Furthermore, it's also worth noting the breakthroughs we are witnessing in gene therapy that hold promise for a long-term cure. Research is actively ongoing, and scientists are working unrelentingly to turn this promise into reality.

In conclusion, hemophilia is a serious genetic disorder that requires regular medical attention and management. While it can be life-threatening, especially if untreated, advancements in medical technology and treatment approach have significantly improved the prognosis for individuals with this disorder. Therefore, an understanding and acknowledgment of this disorder is crucial as it impacts, not just the individual with the condition, but families and the broader society.